Sponsored by: Investment Center

Something new in your business?  Click here to submit your business press release

Chamber Corner | Main Street News | Job Hunt | Classifieds | Calendar | Illinois Lottery 

Endo Pharma paying $1.2 billion for Qualitest

Send a link to a friend

[September 28, 2010]  NEW YORK (AP) -- Drug developer Endo Pharmaceuticals Holdings says it is buying Qualitest Pharmaceuticals for $1.2 Billion in a move to diversify its business and strengthen its position in the generic drug market.

Endo, based in Chadds Ford, Pa., says it will finance the buyout with $500 million in cash, $300 million in credit, and up to $400 million in financing. Endo will retain Qualitest's facilities in Huntsville, Ala., and Charlotte, N.C., as well as its own facility in Westbury, N.Y.

The deal will add about $400 million to Endo's revenue, the company says, and about 40 cents per share in net income. The company reaffirmed its 2010 outlook.

[Associated Press]

Copyright 2010 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Internet

< Recent articles

Back to top


 

News | Sports | Business | Rural Review | Teaching & Learning | Home and Family | Tourism | Obituaries

Community | Perspectives | Law & Courts | Leisure Time | Spiritual Life | Health & Fitness | Teen Scene
Calendar | Letters to the Editor